🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To measure the level of circulating tumor DNA (ctDNA) in the blood of color...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05-17
Trial ID
NCT05900648
Treatments Being Tested
To test the safety of and effectiveness of XmAb20717 for participants with ...
Status
Suspended
Location
M D Anderson Cancer Center
Start Date
2022-08-05
Trial ID
NCT05337735
Treatments Being Tested
The purpose of this study is to identify the recommended dose of vudalimab ...
Status
Terminated
Location
Palo Verde Cancer Specialists
Start Date
2023-12-27
Trial ID
NCT06173505
Treatments Being Tested
This phase I trial tests the safety and effectiveness of vudalimab (XmAb207...
Status
Terminated
Location
Emory University Hospital Midtown
Start Date
2023-08-03
Trial ID
NCT05733351
This is a Phase 1, multiple dose, ascending dose escalation study to define...
Status
Completed
Location
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Start Date
2018-07-10
Trial ID
NCT03517488
Treatments Being Tested
This phase II trial tests whether vudalimab works to shrink tumors in patie...
Status
Suspended
Location
Northwestern University
Start Date
2022-07-21
Trial ID
NCT05453799
Treatments Being Tested
This is a single-arm, phase II clinical trial to evaluate the efficacy of X...
Status
Active Not Recruiting
Location
Abramson Cancer Center at University of Pennsylvania
Start Date
2022-04-11
Trial ID
NCT05297903
Treatments Being Tested
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - NAHOA
Start Date
2022-07-21
Trial ID
NCT05032040
Treatments Being Tested
This Phase 2 study will investigate the safety and clinical activity of vud...
Status
Completed
Location
Alaska Oncology and Hematology
Start Date
2021-10-22
Trial ID
NCT05005728